Duquesne Family Office »

Olema Pharmaceuticals shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Olema Pharmaceuticals (OLMA) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Olema Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Olema Pharmaceuticals held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Olema Pharmaceuticals by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $15M 987k 14.91

More positions owned by Duquesne Family Office

Natera (NTRA)
Ishares Msci Brazil Etf (EWZ)
Insmed Com Par $.01 (INSM)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Call Option (RSP)
Ypf Sociedad Anonima Spon Adr Cl D (YPF)
Bbb Foods Cl A Com (TBBB)
Alcoa (AA)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Sea Sponsord Ads (SE)
Stmicroelectronics N V Ny Registry (STM)
Woodward Governor Company (WWD)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Roku Com Cl A (ROKU)
Broadcom (AVGO)

View all positions for Duquesne Family Office

Top funds holding Olema Pharmaceuticals

Paradigm Biocapital Advisors
Bain Capital Life Sciences Investors
Henderson Group
BlackRock
BVF
FMR
Cormorant Asset Management
Vanguard Group
Siren
Logos Global Management
Vanguard Capital Management
RA Capital Management
State Street Corporation
Jennison Associates
Geode Capital Management

View all funds holding Olema Pharmaceuticals